$435 Million is the total value of Capital Advantage, Inc.'s 82 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
VNE | New | Veoneer Inc | $461,000 | – | 8,377 | +100.0% | 0.11% | – |
SIEGY | New | Siemens AG ADR | $325,000 | – | 5,087 | +100.0% | 0.08% | – |
ABT | New | Abbott Laboratories | $230,000 | – | 3,138 | +100.0% | 0.05% | – |
CRM | New | Salesforce Com | $228,000 | – | 1,432 | +100.0% | 0.05% | – |
CLX | New | Clorox Company | $214,000 | – | 1,420 | +100.0% | 0.05% | – |
DWDP | New | DowDuPont Inc | $206,000 | – | 3,196 | +100.0% | 0.05% | – |
BSCK | New | PwrShrs Corp. Bullet 2020 | $177,000 | – | 8,374 | +100.0% | 0.04% | – |
KMI | New | Kinder Morgan Inc | $142,000 | – | 8,036 | +100.0% | 0.03% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-11-01
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
Microsoft Corp | 39 | Q3 2023 | 1.2% |
Chevron Corp | 39 | Q3 2023 | 1.0% |
Facebook Inc Class A | 39 | Q3 2023 | 1.3% |
AT&T Inc | 39 | Q3 2023 | 0.6% |
Pfizer Incorporated | 39 | Q3 2023 | 0.3% |
Cisco Systems Inc | 39 | Q3 2023 | 0.3% |
Verizon Communications Inc | 39 | Q3 2023 | 0.3% |
iShares Russell 2000 ETF | 38 | Q2 2023 | 1.4% |
Vanguard Dividend Appreciation ETF | 37 | Q3 2023 | 8.4% |
Merck & Co Inc | 37 | Q2 2023 | 0.4% |
View Capital Advantage, Inc.'s complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-14 |
13F-HR | 2024-01-23 |
13F-HR | 2023-10-30 |
13F-HR | 2023-08-07 |
13F-HR | 2023-05-05 |
13F-HR | 2023-01-24 |
13F-HR | 2022-10-31 |
13F-HR | 2022-07-21 |
13F-HR | 2022-05-10 |
13F-HR | 2022-01-21 |
View Capital Advantage, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.